Aflac Incorporated (NYSE:AFL) Shares Sold by American Trust

American Trust cut its position in shares of Aflac Incorporated (NYSE:AFLGet Rating) by 3.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,566 shares of the financial services provider’s stock after selling 214 shares during the quarter. American Trust’s holdings in Aflac were worth $423,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Massmutual Trust Co. FSB ADV increased its position in Aflac by 120.2% during the first quarter. Massmutual Trust Co. FSB ADV now owns 403 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares in the last quarter. Rather & Kittrell Inc. purchased a new position in Aflac during the fourth quarter worth $27,000. Independence Bank of Kentucky increased its position in Aflac by 96.8% during the first quarter. Independence Bank of Kentucky now owns 492 shares of the financial services provider’s stock worth $32,000 after buying an additional 242 shares in the last quarter. CFS Investment Advisory Services LLC increased its position in Aflac by 6,290.9% during the first quarter. CFS Investment Advisory Services LLC now owns 2,291,341 shares of the financial services provider’s stock worth $36,000 after buying an additional 2,255,488 shares in the last quarter. Finally, Rise Advisors LLC increased its position in Aflac by 74.7% during the first quarter. Rise Advisors LLC now owns 573 shares of the financial services provider’s stock worth $37,000 after buying an additional 245 shares in the last quarter. 66.32% of the stock is owned by institutional investors and hedge funds.

Aflac Price Performance

AFL stock opened at $59.50 on Friday. The stock has a 50-day moving average price of $59.30 and a two-hundred day moving average price of $59.55. Aflac Incorporated has a 12-month low of $51.28 and a 12-month high of $67.20. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.28. The company has a market cap of $37.60 billion, a PE ratio of 8.97, a price-to-earnings-growth ratio of 2.22 and a beta of 0.91.

Aflac (NYSE:AFLGet Rating) last issued its quarterly earnings data on Monday, August 1st. The financial services provider reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.27. The company had revenue of $5.40 billion for the quarter, compared to analysts’ expectations of $4.79 billion. Aflac had a return on equity of 12.40% and a net margin of 20.37%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.59 earnings per share. As a group, research analysts predict that Aflac Incorporated will post 5.37 EPS for the current year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 1st. Shareholders of record on Wednesday, August 24th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.69%. The ex-dividend date was Tuesday, August 23rd. Aflac’s dividend payout ratio is presently 24.13%.

Insiders Place Their Bets

In other Aflac news, CFO James Todd Daniels sold 16,946 shares of the business’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $64.03, for a total transaction of $1,085,052.38. Following the transaction, the chief financial officer now owns 53,025 shares in the company, valued at $3,395,190.75. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CFO James Todd Daniels sold 16,946 shares of the business’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $64.03, for a total value of $1,085,052.38. Following the transaction, the chief financial officer now owns 53,025 shares in the company, valued at $3,395,190.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Teresa L. White sold 10,000 shares of the business’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $59.24, for a total value of $592,400.00. Following the completion of the transaction, the insider now owns 134,256 shares in the company, valued at approximately $7,953,325.44. The disclosure for this sale can be found here. Insiders have sold a total of 38,272 shares of company stock worth $2,338,959 over the last quarter. 1.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Piper Sandler lowered their price objective on Aflac from $68.00 to $66.00 and set an “overweight” rating for the company in a research report on Friday, July 8th. Evercore ISI lowered their price objective on Aflac from $60.00 to $59.00 and set an “in-line” rating for the company in a research report on Wednesday, July 6th. JPMorgan Chase & Co. lifted their price objective on Aflac from $61.00 to $62.00 in a research report on Monday, July 11th. Morgan Stanley lifted their price objective on Aflac from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, August 17th. Finally, Citigroup assumed coverage on Aflac in a research report on Monday, May 23rd. They issued a “neutral” rating and a $60.00 price objective for the company. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus price target of $62.17.

About Aflac

(Get Rating)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLGet Rating).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.